Gammadelta T cells for immune therapy of patients with lymphoid malignancies. [electronic resource]
Producer: 20030819Description: 200-6 p. digitalISSN:- 0006-4971
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Diphosphonates -- administration & dosage
- Dose-Response Relationship, Drug
- Female
- Humans
- Immunotherapy -- methods
- Interleukin-2 -- administration & dosage
- Lymphocyte Activation -- drug effects
- Lymphoma, B-Cell -- drug therapy
- Male
- Middle Aged
- Multiple Myeloma -- drug therapy
- Pamidronate
- Pilot Projects
- Receptors, Antigen, T-Cell, gamma-delta
- Remission Induction
- Salvage Therapy
- T-Lymphocytes -- cytology
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.